Moderna

Despite the nation reaching the grim milestone of 1 million COVID deaths, ODH Director Dr. Bruce Vanderhoff says Ohio is doing "well" compared to previous spikes.

The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.

No deaths were reported in tests, and there were no signs of myocarditis, or heart inflammation, as a side effect.

While approval would only be for those populations, an infectious disease specialist from Mount Carmel Medical Group says may be good for everyone.

If approved, this would be the second booster shot Moderna has issued for people ages 18 and up.

Now, both the Pfizer and the Moderna booster shots can be given five months after the second dose of vaccine — down from six months.

Nearly 110 million Americans have been vaccinated against COVID-19. And delivering each dose requires a complex chain of events. This is the story of one of those doses — and how it ended up in Archie Thomas’ left arm at a church recreation center in Evansville, Indiana.

Researchers hope to learn about the effectiveness of the vaccine for kids ages 6 months to less than 12 years old. Moderna plans to enroll roughly 6,750 children in eight U.S. states and Canada.

Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.

As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over.